Antimitotic Agents: all 5,052 studies that test it
Page 38 of 51. Open to participants first (616), then studies with results posted, then the rest; newest registration first within each.
- A Phase II Study of Doxorubicin, Cyclophosphamide and Vindesine With Valproic Acid in Patients With Refractory or Relapsing Small Cell Lung Cancer After Platinum Derivatives and EtoposideCompletedNCT00759824Phase 2
- Safety Study of XL147 (SAR245408), in Combination With Paclitaxel and Carboplatin in Adults With Solid TumorsCompletedNCT00756847Phase 1
- Metronomic Vinorelbine and Bevacizumab in Patients With Non Small Cell Lung CancerCompletedNCT00755170Phase 2
- Metronomic Docetaxel and Bevacizumab in Patients With Small Cell Lung CancerWithdrawnNCT00755157Phase 2
- Targeting Inflammation in Acute Coronary Syndrome Using ColchicineCompletedNCT00754819Phase 2/3
- Vinorelbine Metronomic Plus Lapatinib for Overexpressing HER-2 Metastatic Breast CancerTerminatedNCT00754702Phase 2
- Docetaxel, Gemcitabine and Bevacizumab for Metastatic Breast CancerCompletedNCT00754351Phase 2
- Paclitaxel, Carboplatin Plus Bevacizumab in Pretreated, Advanced or Metastatic Non Small Cell Lung CancerCompletedNCT00753909Phase 2
- Phase 2 Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Patients With Head and Neck CarcinomaCompletedNCT00753038Phase 2
- FEC With G-CSF Support Followed by Ixabepilone With G-CSF Support as Neoadjuvant Chemotherapy in BCCompletedNCT00751868Phase 2
- Prevention of Sagopilone-induced Neurotoxicity With Acetyl-L-Carnitine (ALC)CompletedNCT00751205Phase 2
- Paclitaxel and Carboplatin Combination as 1st Line Treatment in Ovarian CarcinomasCompletedNCT00750386Phase 1/2
- Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Sunitinib as First-Line Therapy in Treating Patients With Stage IV Non-Small Cell Lung CancerWithdrawnNCT00748163Phase 2
- Docetaxel Plus Bevacizumab in Metastatic Non Small Cell Lung CancerCompletedNCT00741195Phase 2
- Oxaliplatin and 5-Fluorouracil With or Without Docetaxel in Elderly Patients (>65 y) With Stomach and Esophagus CancerCompletedNCT00737373Phase 2
- First-Line Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Cannot Be Removed by SurgeryStatus unknownNCT00736814Phase 2
- Safety and Exploratory Efficacy of Kanglaite Injection in Pancreatic CancerCompletedNCT00733850Phase 2
- Efficacy and Safety Study of Combination Therapy With Docetaxel-oxaliplatin-capecitabine in Patients With Advanced Gastric Adenocarcinoma and Intermediate General StatusCompletedNCT00733616Phase 2
- Hepatic Arterial Infusion (HAI) of AbraxaneCompletedNCT00732836Phase 1
- Phase I, Pharmacokinetic, Pharmacodynamic Trial of PTK787 and Paclitaxel in Combination for Advanced Solid TumorsCompletedNCT00731861Phase 1
- A Phase I Trial of Abraxane, Cisplatin and 5-Fluorouracil Along With Chemoradiotherapy in Advanced Head and Neck CancerCompletedNCT00731380Phase 1
- Docetaxel and Cetuximab in Treating Patients With Metastatic Prostate CancerCompletedNCT00728663Phase 2
- Phase 1b Study of Indibulin in Combination With Capecitabine in Advanced Solid TumorsTerminatedNCT00726687Phase 1
- Concomitant Chemoradiotherapy With Weekly Paclitaxel and Vinorelbine and Granulocyte Colony Stimulating Factor (GCSF) Support in Patients With Advanced Breast CancerCompletedNCT00724386Phase 1
- A Trial of ALB 109564(a) in Subjects With Advanced Solid TumorsTerminatedNCT00724100Phase 1
- Evaluation of Therapeutic Effect of 0.5 mg Colchicine and 5 mg Prednisolone on Oral AphthaeStatus unknownNCT00723268Phase 2
- Japanese Study of the Combined Administration of Docetaxel With Prednisolone for Metastatic Hormone Refractory Prostate CancerCompletedNCT00723086Phase 2
- Platinum Resistant Ovarian Cancer Evaluation of Doxil and Vintafolide (MK-8109, EC145) Combination Therapy (8109-009, EC-FV-04)CompletedNCT00722592Phase 2
- AVE8062 in Combination With Platinum-taxane Doublet in Advanced Solid TumorCompletedNCT00719524Phase 1
- Postoperative Chemotherapy and Chemo-radiotherapy for Resected Gastric CancerCompletedNCT00718913Phase 2
- Irinotecan, Vincristine, and Dexamethasone In Children With Relapsed And/Or Refractory Hematologic MalignanciesCompletedNCT00718757Phase 1
- A Randomised,Multi-Center Study of Docetaxol Plus Capecitabine or Cisplatin in Anthracycline-Pretreated Patients With Advanced Breast CancerStatus unknownNCT00717951Phase 2
- Solid Tumors Using Ixabepilone and DasatinibCompletedNCT00717704Phase 1
- Patupilone (EPO 906) in Patients With Recurrent or Progressive GlioblastomaCompletedNCT00715013Phase 1/2
- Phase II Study of Docetaxel for Clinically Asymptomatic High Risk Prostate Cancer PatientsTerminatedNCT00714376Phase 2
- Bortezomib (PS-341) in Combination With Carboplatin and Docetaxel for Patients With Advanced Non-Small Cell Lung CancerTerminatedNCT00714246Phase 1
- Study Of SU011248 In Combination With Docetaxel In Patients With Advanced CancerCompletedNCT00712504Phase 1
- Phase I/II Study of AZD2281 Given in Combination With Paclitaxel in Metastatic Triple Negative Breast CancerCompletedNCT00707707Phase 1
- Two Combination Chemotherapy Regimens in Treating Children With Newly Diagnosed Acute Lymphoblastic LeukemiaCompletedNCT00707083Phase 3
- Vinorelbine Oral Plus Capecitabine Combination In Metastatic Breast CancerCompletedNCT00706069Phase 1
- Combination of Docetaxel + Estramustine + Hydrocortisone Versus Docetaxel + Prednisone in Patients With Advanced Prostate CancerTerminatedNCT00705822Phase 3
- Individualized Therapy Based of Tumoral mRNA Levels of ERCC1, RRM1 and BRCA1 in Advanced Non-Small-Cell Lung CancerTerminatedNCT00705549Phase 2
- Docetaxel/Epirubicin/Bevacizumab as First Line Therapy for Metastatic HER2 Negative Breast CancerCompletedNCT00705315Phase 1/2
- Phase I Study of Docetaxel and Temsirolimus in Resistant Solid MalignanciesCompletedNCT00703625Phase 1
- Target Dosing of Docetaxel Through Pharmacokinetic/Pharmacodynamic Optimisation of the First Chemotherapeutic CycleCompletedNCT00703378Phase 1/2
- Study of Combination Therapy of Carboplatin -Gemcitabine Plus Bevacizumab Beyond Progression in Patients With Locally Advanced and/or Metastatic Non-small Cell Lung Cancer (NSCLC) Who Have Not Received Prior Systemic TherapyCompletedNCT00702975Phase 2
- Carboplatin, Paclitaxel, Bevacizumab and Vorinostat for Patients With Advanced Non-Small Cell Lung CancerTerminatedNCT00702572Phase 1
- Study of Oral Vinorelbine and Erlotinib in Non-Small Cell Lung CancerCompletedNCT00702182Phase 1
- Colchicine Randomized Double-Blind Controlled Crossover Study in Behcet's DiseaseCompletedNCT00700297Phase 2
- A Study of AVE8062 in Advanced-stage Soft Tissue Sarcoma After Failure of Anthracycline and Ifosfamide ChemotherapiesCompletedNCT00699517Phase 3
- A Safety and Efficacy Trial of Amplimexon Plus Taxotere in Metastatic Non-Small Cell Lung CancerWithdrawnNCT00697060Phase 2
- The Effect of Docetaxel or Gemcitabine-based Chemotherapy in East Asian and Caucasian PatientsCompletedNCT00695994Phase 2
- Vinorelbine Metronomic Plus Bevacizumab as Salvage Therapy for Breast CancerTerminatedNCT00694200Phase 2
- Therapy of Metastatic Breast Cancer With Paclitaxel and Liposomal DoxorubicinTerminatedNCT00691912Phase 2
- Weekly Paclitaxel/Carboplatin/Bevacizumab as First Line Therapy for Triple Negative Breast CancerCompletedNCT00691379Phase 1/2
- Docetaxel Plus Oxaliplatin as Therapy in Patients With Pancreatic CancerStatus unknownNCT00690300Phase 2
- Epirubicin or Not in Patients With TOP2A (Topoisomerase (DNA) II Alpha (170kD)) Normal Early Breast CancerCompletedNCT00689156Phase 3
- Study of Bavituximab Plus Paclitaxel and Carboplatin in Patients With Non-Small Cell Lung CancerCompletedNCT00687817Phase 2
- Evaluation of Paclitaxel (Taxol, NSC #673089), Carboplatin (Paraplatin, NSC #241240), and BSI-201 (NSC #746045, IND #71,677) in the Treatment of Advanced, Persistent, or Recurrent Uterine CarcinosarcomaCompletedNCT00687687Phase 2
- Docetaxel - Carboplatin As Second Line Treatment in Patients with Small Cell Lung CancerCompletedNCT00686985Phase 2
- Concurrent Chemoradiotherapy (CCRT) With Paclitaxel Plus Cisplatin in LA Non-small-cell Lung Cancer (NSCLC)CompletedNCT00686322Phase 4
- An Efficacy Study of Milataxel (TL139) Administered Orally for Malignant MesotheliomaStatus unknownNCT00685204Phase 2
- Docetaxel/Pemetrexed as 1st Line Treatment in Patients With Non Small Cell Lung Cancer (NSCLC)CompletedNCT00684099Phase 1/2
- Single Agent Abraxane as Second Line Therapy in Bladder CancerCompletedNCT00683059Phase 2
- Combined Modality Therapy With Growth Factor Support in Locally Advanced Non-small Cell Lung Cancer (NSCLC)CompletedNCT00682383Phase 2
- Cisplatin, Paclitaxel, and Everolimus in Treating Patients With Metastatic Breast CancerCompletedNCT00680758Phase 1
- Fludeoxyglucose F 18-PET/CT Imaging in Assessing Response to Chemotherapy in Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Hodgkin LymphomaCompletedNCT00678327Phase 3
- A Phase II Study of Docetaxel Plus Carboplatin in Chemonaive Hormone-Refractory Prostate Cancer (HRPC) PatientsCompletedNCT00675545Phase 2
- The Effect of Preoperative Docetaxel, Cisplatin and Capecitabine on Serum RUNX3 Hypermethylation Status in Patients With Gastric and Lower Oesophagus AdenocarcinomaStatus unknownNCT00674167Phase 2
- A Study of Ixabepilone Before Surgery for High-Risk Localized Prostate CancerTerminatedNCT00672009Phase 2
- Validate Gene Expression and Proteomic Signatures Predictive of Treatment for Response for Breast Cancer PatientStatus unknownNCT00669773Phase 2
- Biweekly Docetaxel in Combination With Capecitabine as First-Line Treatment in Patients With Advanced Gastric CancerStatus unknownNCT00669370Phase 2
- Adjuvant Treatment of Breast Cancer With 1-3 Aflicted Lymph NodesCompletedNCT00668616Phase 3
- Paclitaxel and Bortezomib in Treating Patients With Metastatic or Unresectable Malignant Solid TumorsCompletedNCT00667641Phase 1
- Efficacy Study of CYT997 in Multiple MyelomaTerminatedNCT00664378Phase 2
- A Bioequivalence Study of Docetaxel for Injectable Emulsion (ANX-514) in Patients With Advanced CancerCompletedNCT00664170Phase 1
- Phase II Study of ABI-007 for Gastric CancerCompletedNCT00661167Phase 2
- Evaluation of KX2-391 in Patients With Advanced MalignanciesCompletedNCT00658970Phase 1
- Efficacy Study of Chemotherapy to Treat Ovarian Cancer Recurrence by Prolonging the Platinum Free IntervalStatus unknownNCT00657878Phase 3
- Phase 1 Study of MKC-1 in Patients With Advanced CancerCompletedNCT00656461Phase 1
- Adjuvant Treatment of Prostate Cancer With Docetaxel or Not After Radical RadiotherapyStatus unknownNCT00653848Phase 3
- Intraperitoneal Paclitaxel and Carboplatin With IV Avastin Therapy in Patients With Carcinomas of Mullerian OriginStatus unknownNCT00652119Phase 1
- Study to Evaluate KOS-1584 in Patients With Advanced or Metastatic Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00651508Phase 2
- Androgen Suppression and Radiation With/Out Docetaxel in High-Risk Localized Prostate CancerTerminatedNCT00651326Phase 3
- Efficacy Study of CYT997 in Combination With Carboplatin in GlioblastomaTerminatedNCT00650949Phase 1/2
- Epirubicin, Docetaxel, and Capecitabine in Treating Women With Stage IIIA or Stage IIIB Breast CancerCompletedNCT00645866Phase 2
- Safety Study of Oral Vinorelbine in Subjects With Non-Hematologic MalignanciesStatus unknownNCT00641160Phase 1
- Dose Escalation Study of Liposomal Paclitaxel With/Without Capecitabine in Patients With Advanced Gastric CarcinomaStatus unknownNCT00639522Phase 1
- Paricalcitol and Chemotherapy in Treating Women With Metastatic Breast CancerCompletedNCT00637897Phase 1
- A Study of ARRY-520 in Patients With Advanced Myeloid LeukemiaCompletedNCT00637052Phase 1/2
- Methotrexate, Vinblastine, Doxorubicin and Cisplatin (MVAC) Followed by Gemcitabine Plus Cisplatin (GEM+CDDP) in Locally Advanced or Metastatic Bladder CancerTerminatedNCT00635726Phase 2
- Phase 1 Study of MPC-6827 and Carboplatin in Recurrent/Relapsed Glioblastoma MultiformeStatus unknownNCT00635557Phase 1/2
- Phase 1/2 Study of Vascular Disrupting Agent NPI-2358 + Docetaxel in Patients With Advanced Non-Small Cell Lung CancerCompletedNCT00630110Phase 1/2
- Sequential Versus Simultaneous Use of Vinorelbine and Capecitabine in Patients With Metastatic Breast Cancer (MBC)CompletedNCT00629148Phase 2
- Mitoxantrone, Etoposide, and Vinorelbine As Second-Line Therapy in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone TherapyCompletedNCT00627354Phase 2
- Docetaxel and S-1 Followed By Radiation Therapy and Low-Dose Cisplatin in Treating Patients With Stage III or Stage IV Head and Neck CancerStatus unknownNCT00625937Phase 2
- Larotaxel + Cisplatin Versus Gemcitabine + Cisplatin in First Line Treatment of Locally Advanced/Metastatic Urothelial Tract or Bladder CancerCompletedNCT00625664Phase 3
- Phase II Trial of Abraxane and Capecitabine in Metastatic Colon Cancer (COL 01)CompletedNCT00625573Phase 2
- Randomised Study Comparing Three Chemotherapy Regimens in Non-small Cell Lung CancerCompletedNCT00622349Phase 3
- Cisplatin/Vinorelbine/Bevacizumab Followed by Docetaxel/Gemcitabine/Bevacizumab Versus the Cisplatin/Docetaxel/Bevacizumab Combination in Locally Advanced or Metastatic NSCLCCompletedNCT00620971Phase 2